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Abstract. The carboxy-terminal tail domains of neu- 
rofilament subunits neurofilament NF-M and NF-H 
have been postulated to be responsible for the modula- 
tion of axonal caliber. To test how subunit composition 
affects caliber, transgenic mice were generated to in- 
crease axonal NF-M. Total neurofilament subunit con- 
tent in motor and sensory axons remained essentially 
unchanged, but increases in NF-M were offset by pro- 
portionate decreases in both NF-H and axonal cross- 
sectional area. Increase in NF-M did not affect the level 
of phosphorylation of NF-H. This indicates that (a) in 
vivo NF-H and NF-M compete either for coassembly 
with a limiting amount of NF-L or as substrates for ax- 
onal transport, and (b) NF-H abundance is a primary 
determinant of axonal caliber. Despite inhibition of ra- 
dial growth, increase in NF-M and reduction in axonal 
NF-H did not affect nearest neighbor spacing between 
neurofilaments, indicating that cross-bridging between 
nearest neighbors does not play a crucial role in radial 
growth. Increase in NF-M did not result in an overt 
phenotype or neuronal loss, although filamentous 
swellings in perikarya and proximal axons of motor 
neurons were frequently found. 
N 
EUROFILAMENTS, the  8-10-nm  intermediate  fila- 
ments  of  most  neurons,  are  coassembled  from 
three subunits, NF-L, NF-M, and NF-H, with ap- 
parent molecular masses of 68,  150,  and 200 kD, respec- 
tively. While all three proteins have the ~310--amino acid 
conserved helical domain that is shared by most cytoplas- 
mic  intermediate  filament  subunits,  they  differ  in  size 
mainly by their carboxy-terminal tail domains (Geisler et 
al., 1983). In mature myelinated axons, neurofilaments are 
assembled into parallel arrays of long polymers, and are 
the  most abundant  cytoskeletal elements,  outnumbering 
microtubules by up to an order of magnitude. The caliber 
of its axon is an important feature of a neuron because ax- 
onal diameter directly governs conduction velocity in my- 
elinated fibers (Gasser and Grundfest, 1939), and may be 
a trigger for myelination (Arbuthnott et al., 1980; Voyvodic, 
1989).  An initial proposal that neurofilaments are a major 
determinant of axon caliber arose from observing a nearly 
constant  density of neurofilaments during  the  axonal ra- 
dial growth that begins during myelination and continues 
Address  all  correspondence  to  Dr.  Don  Cleveland,  Ludwig  Institute/ 
UCSD, 3080 CMM-East, Mailcode 0660, 9500 Gilman Drive, La Jolla, CA 
92093. Tel.: (619) 534-7802.  Fax: (619) 534-7659. 
throughout adult life (Friede and Samorajski, 1970; Hoff- 
man et al., 1987; Cleveland et al., 1991). It is now apparent 
that neurofilament content is a primary influence, and not 
a consequence, of axonal caliber. This has been proven un- 
equivocally to be true in a mutant Japanese quail, in which 
premature translation termination of NF-L blocks filament 
assembly (Ohara et al., 1993), and the resultant axons fail 
to grow radially (Sakaguchi et al., 1993). This has also been 
shown in mice, where the expression of a  mutant NF-H 
subunit  fused to the full coding sequence  of 13-galactosi- 
dase blocks filament transport into axons and profoundly in- 
hibits radial growth (Eyer and Peterson, 1994). 
It is also now clear that the general relationship of neu- 
rofilament content and caliber is modulated by the relative 
degree of phosphorylation of NF-M and NF-H. In vitro as- 
sembly studies have shown that the extended carboxy-ter- 
minal tail domains of NF-M and NF-H are responsible for 
the  formation of side  arm structures  that protrude  from 
the core 10-nm filament (Geisler et al., 1984; Hirokawa et 
al., 1984). These side arms may modulate axonal caliber by 
regulating  the  spacing  between  adjacent  neurofilaments 
and/or spacing between neurofilaments and other axonal 
components. Since the tail domain of NF-H (and to a lesser 
extent, NF-M) contains multiple repeats of lysine-serine- 
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vide potential phosphorylation sites (Geisler et al., 1983; 
Lees et al., 1988), phosphorylation is an attractive candi- 
date  for regulating  filament interactions.  Evidence sup- 
porting the idea that phosphorylation can regulate axonal 
caliber has emerged from the Trembler mouse. Hypomy- 
elination in this mutant mouse correlates with reduction in 
phosphorylation of neurofilaments and inhibition of radial 
growth (de Waegh et al., 1992). Further, unmyelinated ini- 
tial  axonal  segments  have  unphosphorylated  neurofila- 
ments that are closely packed, and are smaller in diameter 
than the adjacent myelinated segments (Hsieh et al., 1994; 
Nixon et al., 1994). 
An important remaining question is how neurofilament 
investment defines caliber, and what role individual sub- 
units play in the event. There have been no previous inves- 
tigations in which selective reduction in NF-H content was 
achieved. Similarly, there are no previous assessments of 
the effect of modifying the content of individual neurofila- 
ment  subunits  on  axonal  caliber.  To  begin  to  evaluate 
these questions, we have now used an epitope-tagged NF-M 
subunit to increase NF-M levels in transgenic mice and to 
analyze the effect of altered neurofilament subunit content 
on radial growth of motor and sensory axons and on fila- 
ment-filament spacing. 
Materials and Methods 
Construction of Transgenic Mice 
Expression pMSV-NFM-Cz~50 
Plasmid pMSV-NFM-CA50 encoding a murine NF-M in which the car- 
boxy-termina150 amino acids were substituted with a 12-amino acid myc- 
epitope tag has been previously described (Wong and Cleveland, 1990). 
This  hybrid  NF-M  gene, which also contains a  murine  sarcoma virus 
(MSV)  1 promoter substituted in place of the proximal NF-M promoter 
domain, was excised using ClaI and BamHI, gel purified, and microin- 
jected into one-cell stage, hybrid (C57 B6/A) mouse embryos as previ- 
ously described (Monteiro et al.,  1990).  Founder mice were unambigu- 
ously  identified to  be  transgenic by  genomic DNA  blotting  of DNA 
isolated from mouse tail (Xu et al., 1993). 
SDS-PAGE and Immunoblotting 
Total protein extracts from mouse tissues were homogenized in buffer 
containing 25 mM sodium phosphate pH 7.2, 5 mM EGTA, 1% SDS and 
i mM PMSF and boiled for 10 min. After determining the protein concen- 
tration using the bicinchronic-acid assay (Smith et al., 1985), 20 }xg of total 
protein for each tissue was loaded onto a 7.5% polyacrylamide gel, elec- 
trophoresed, and transferred onto nitrocellulose filters as previously de- 
scribed  (Lopata  and  Cleveland,  1987).  Endogenous NF-M  and  NFM- 
CA50 were detected using a mAb against NF-M (Boehringer Mannheim 
Corp.,  Biochemicals  Division,  Indianapolis,  IN)  and  NFM-CA50  was 
detected specifically using mAb 9E10  (Evan  et  al.,  1985)  followed by 
125I-labeled  sheep  anti-mouse.  Quantitative  immunoblotting  was  per- 
formed using a dilution series of known amounts of NF-L, NF-M, NF-H, 
and myc-trpE fusion protein standards electrophoresed on the same blot. 
Signals were quantified using a  PhosphorImager (Molecular Dynamics, 
Inc., Sunnyvale, CA). 
Immunocytochemistry 
Immunocytochemistry on 1-lxm cryosections was performed according to 
procedures reported previously (Stoll et al., 1989). Briefly, sciatic nerves 
were infiltrated for 1 d each with 1, 2, and 2.3 M sucrose in 30% polyvi- 
nylpyrrolidone. The specimens were frozen in liquid nitrogen and 1-1xm 
1. Abbreviations  used in this paper:  ALS, amyotrophic lateral sclerosis; 
MSV, murine sarcoma virus. 
sections were cut with an ultramicrotome (Reichert Scientific Instruments, 
Div.  Warner-Lambert Technologies, Inc.,  Buffalo,  NY)  maintained  at 
-90°C. The sections were transferred in sucrose-containing loops to gela- 
tin-subbed slides and stained by the avidin-biotin-peroxidase complex 
technique (Hsu et al., 1981). 
Immunofluorescence and Con  focal Laser 
Scanning Microscopy 
Dissected spinal cords were cryoprotected for 24 h in PBS containing 20 % 
glycerol and then sectioned with a freezing microtome. 40-~.m-thick  sec- 
tions were rinsed in PBS, incubated for 24 h in PBS containing 2.5% Tri- 
ton X-100, and then blocked for 30 min with 5% normal horse serum. Sec- 
tions were incubated for 24  h  at  4°C in  1%  Triton X-100/PBS plus a 
combination of a  mAb against an epitope tag from human myc (9El0; 
Evan et al., 1985) and a rabbit polyclonal antibody generated against a 15- 
mer oligopeptide (CYEKTTEDKATKGEK) whose final 13 amino acids 
correspond to the extreme carboxy terminus of murine NF-H (see Xu et 
al., 1993). Sections were washed for 2 h in a mixture of FITC-sheep anti- 
mouse and Texas red--donkey anti-rabbit secondary antibodies (Amer- 
sham Corp., Arlington Heights, IL). Finally, the sections were washed in 
PBS and mounted in a fade-resisting mounting medium containing para- 
phenylene diamine. 
Sections were examined either with standard epifluorescence on a mi- 
croscope (BH2; Olympus Corporation of America, New Hyde Park, NY) 
or with a eonfocal laser scanning microscope (Leica Inc., Deerfield, NY). 
For the latter, optical sections of ,-~1 ~m thick were collected using a line 
averaging technique. The Texas red and FITC images were collected si- 
multaneously. 
Electron Microscopy, Morphological 
and Morphometric Analysis 
For electron microscopy, tissues were fixed by intracardial perfusion with 
0.1 M sodium phosphate (pH 7.6), 4% paraformaldehyde, and 2,5% gin- 
taraldehyde. Tissue samples removed after dissection were immersed in 
the same fixative for 24 h at 4°C, postfixed for 2 h with 2% osmium tetrox- 
ide in 0.1 M phosphate buffer, dehydrated in a graded alcohol series, and 
embedded in LX-112 (Ladd Research Industries, Inc., Burlington, VT). 
l-p,m sections were stained with toluidine blue and examined by light mi- 
croscopy; subsequent thin sections (100  nm) were cut and stained with 
uranyl acetate and lead citrate, and examined in an electron microscope 
(1-I-600; Hitachi Instruments, Inc., San Jose, CA). 
Microscopic video images of the 1-1~m sections at a light magnification 
of 100 were digitized using a frame grabber board and image analysis soft- 
ware (Bioquant; R&M Biometrics, Inc., Memphis, TN).  The  cross-sec- 
tional axonal area of myelinated axons >1.5 }~m  2 were measured in con- 
tinuous nonoverlapping fields with center-of-gravity exclusion to  avoid 
double counting. The illumination and optimum gray-scale pixel value for 
discrimination of the myelin/axon border was chosen independently for 
each field to minimize systematic bias for a section. Results are reported 
as the diameter of a circle of equivalent area to the axon. 
Analysis of Filament Spacing: 
Nearest Neighbor Analysis 
To measure nearest neighbor distances between neurofilaments, cross sec- 
tions of axons >3.0 }xm in diameter were photographed at a magnification 
of 20,000 and enlarged an additional fivefold by printing. Neurofilaments 
were identified in these end-on views as dots of ~10 nm in diameter. Posi- 
tions of neurofilaments were marked by puncturing the print with a push- 
pin. By laying the final prints on a light box, neurofilament positions could 
easily be imaged using a CCD camera, digitized using image analysis software 
(Bioquant), and nearest neighbor distances calculated for each filament. 
Results 
Expression of an Epitope-tagged, Assembly Competent 
NF-M in Neurons of Transgenic Mice 
To  examine  the  consequence  of expressing  an  epitope- 
tagged NF-M subunit in a true in vivo context, transgenic 
mice were produced that carry an NF-M transgene in which 
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and accumulation  of epitope-tagged NFM in transgenic mice. (A) 
Schematic  drawing  of the pMSV-NFM-CA50 gene in which the 
sequences encoding the carboxy-termina150 amino acids of NF-M 
as well as the entire 3' untranslated and 3' gene flanking regions 
have  been  replaced  by  sequences  encoding  a  12-amino  acid 
epitope tag (MEQKLISEEDLN) followed by a TGA stop codon, 
and the 3'untranslated and 3' flanking regions of the mouse NF-L 
gene.  Darkly  stippled domain, MSV  promoter; filled  domains, 
NF-M exons; open domains, NF-M introns;  horizontally striped 
domain, myc epitope tag; stippled domain, NF-L 3' untranslated 
and flanking  region.  (B)  Schematic  drawing  of the NF-M  poly- 
peptide.  The  helical  rod  domain  is  bounded  by amino acids 
104-411. The tail  domain is characterized by a phosphorylated 
domain  containing  lysine-serine-proline  repeats  (amino  acids 
500-610) and a region containing  a highly conserved domain rich 
in lysine and glutamic  acid (amino acids 758--838). The deletion 
end point (and site of epitope tag addition)  for the NFM-CA50 
polypeptide is indicated  by the arrow. (C) 20 Ixg of total proteins 
extracted from various  tissues  of a  1.5-mo-old  NFM-CA50(42) 
mouse were separated on a 6% polyacrylamide gel and immuno- 
blotted using (top row) the myc-9E10 antibody recognizing  only 
the NFM-CA50 transgenic  product, (middle row) the RMO255 
mAb (kindly provided by V. M.-Y. Lee) which binds only to the 
endogenous  NF-M, or (bottom row) an anti-NF160 mAb (Boeh- 
ringer Mannheim Corp.) which  recognizes  both the transgenic 
product and the endogenous NF-M. Lane 1: cerebral cortex; lane 
2: cerebellum; lane 3: optic nerve; lane 4: sciatic nerve; lane 5" spi- 
nal cord; lane 6: skeletal muscle; lane 7: kidney;  lane 8: spleen; 
lane 9: liver; lane 10: heart; lane 11: eye. 
the  NF-M  promoter  was  substituted  with  the  promoter 
from MSV. This hybrid gene, MSV-NFM-CA50 (Fig. 1 A), 
encodes a mouse NF-M subunit (Fig. 1 B) that is identical 
to the endogenous mouse NF-M, except for substitution of 
the  carboxy-terminal  50  amino  acids  of  the  438-amino 
acid tail  domain with a  12-amino acid epitope tag (from 
human  myc; see  Materials  and  Methods).  The  resultant 
NF-M polypeptide contains intact head and rod domains 
required  for filament assembly and  transfection  analyses 
into cells expressing vimentin (Wong and Cleveland, 1990), 
NF-L (Lee et al., 1993), or NF-L and NF-H (data not shown) 
have demonstrated it to coassemble perfectly into extended 
arrays of cytoplasmic filaments. Further, use of baculovi- 
rus to coexpress NF-L and a myc-tagged NF-M truncated 
by 95 amino acids yields crossbridged filaments whose ul- 
trastructure and spacing precisely reproduce that seen for 
NF-L  and  wild-type  NF-M  (Nakagawa  et  al.,  1995).  In 
view of this, it seems likely that the epitope-tagged subunit 
shares most or all of the assembly and functional proper- 
ties of the wild-type subunit. 
12 lines of mice were established using methods previ- 
ously described (Monteiro et al., 1990)  and the two highest 
expressing lines NFM-CA50(2)  and  NFM-CA50(42)  were 
examined in  detail.  To determine in what  tissues  and to 
what  level the  transgene-encoded  NF-M  was  expressed, 
whole-cell  proteins  from  11  different  tissues  from  both 
transgenic lines 2  and 42 were immunoblotted with anti- 
bodies recognizing  the  epitope tag  on  transgenic NF-M. 
Fig. 1 C displays the results for an 1.5-mo-old animal from 
line 42. Similar to the neuron-specific expression of the en- 
dogenous NF-M subunits (identified by antibody RMO255; 
Balin and Lee, 1991), an antibody to the myc epitope tag 
revealed transgenic NF-M to be found primarily in nervous 
tissues (e.g., optic nerve, sciatic nerve, spinal cord; Fig.  1 
C, lanes 3-5). Using known amounts of purified NF-M or 
recombinant,  epitope-tagged  protein  as  quantification 
standards and an antibody (RMO255; Balin and Lee, 1991) 
that  binds  at  the  carboxy terminus  of NF-M  truncated 
from the transgene-encoded NF-M, phosphorimaging was 
used to determine that transgenic NF-M accumulated to 
~180% the level of endogenous NF-M in sciatic nerve. As 
seen  previously  with  other  MSV-promoted  genes  (e.g., 
Monteiro et al., 1990),  transgene expression was also ob- 
served in  some nonneuronal  tissues  (between ~0.05  and 
0.5%  of total cell protein in skeletal muscle, kidney, car- 
diac muscle, and eye) (Fig. 1 C, top row, lanes 6, 7, 10, 11). 
In skeletal muscle, transgene expression progressively de- 
clined with age, becoming undetectable  by three months 
(not shown). 
To determine in neuronal tissues whether the transgene 
product was expressed solely or predominantly in the neu- 
rons,  sciatic  nerves  and  spinal  cords  from  control  and 
NFM-CA50 mice were cryoprotected, and frozen sections 
were immunostained for the transgene product or for en- 
dogenous NF-H. In sciatic nerve (Fig. 2 B), both large and 
small caliber axons, but not Schwann cells, stained heavily 
with an mAb (9El0) that recognizes the transgene epitope 
tag. No such signal was detected in any axon from control 
nerve (Fig. 2 A), although using a mAb specific for phos- 
phorylated NF-H (SMI-31; Sternberger  and  Sternberger, 
1983),  all axons from both control and transgenic nerves 
stained  intensely  (Fig.  2,  C  and D).  These results reveal 
that  transgenic  NFM-CA50  apparently  accumulates  to 
comparable  levels  in  most  of the  axons  comprising  the 
nerve. 
Sections  of spinal cord also yielded intense  staining in 
axons (Fig. 2 F, inset)  throughout the cords of transgenic 
animals, as well as in motor neuron perikarya (arrows, Fig. 
2  F).  Furthermore,  with  the  epitope tag  antibody and  a 
polyclonal antibody generated against the carboxy-termi- 
nal 15 amino acids of NF-H (Xu et al., 1993), confocal mi- 
croscopy of these same samples revealed that NFM-CA50 
(Fig. 2  G) colocalized with endogenous NF-H (Fig. 2 H). 
Similar results were  obtained when NFM-CA50  localiza- 
tion  was  compared  with  NF-L  (not  shown).  Taken  to- 
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cell bodies and axons of the spinal cord and sciatic nerve. (A-D) 
Frozen sections (1 txm) of sciatic nerves from 2-mo-old control (-4 
and C) and NFM-CA50(42)  (B and D) mice stained (A and B) 
with an mAb (9E10)  that recognizes the epitope tag on NFM- 
CA50 and (C and D) an anti-NF-H (SMI-31) mAb. Arrows in (B) 
point to two  of the many intensely stained axons in the NFM- 
CA50(42) mouse. Bar, 20 p,m. (E and F) Frozen sections (40 txm) 
of spinal cords from (E) control and (F) NFM-CA50(2) mice (1.5- 
mo-old)  stained  with  the  mAb  recognizing  the  NFM-CA50 
epitope tag. Arrows point to a cluster of three motor neuron cell 
bodies with abundant NFM-CA50, and the arrowhead in the inset 
highlight  the axons with accumulation of the transgene product. 
Bar,  100  Ixm. (G and H)  Anterior horn motor neurons from 
NFM-CA50(2)  spinal cord (as in F) subjected to indirect double 
immunofluorescence and confocal microscopy.  The section was 
costained for both the transgenic product using (G) the epitope 
tag  antibody 9E10  and  (/4)  a  polyclonal antibody produced 
against carboxy terminus of mouse NF-H, followed  by (G) fluo- 
rescein-conjugated horse  anti-mouse IgG and (H)  Texas red- 
conjugated goat anti-rabbit IgG. Bar, 50 p.m. 
gether,  these  immunocytochemical analyses demonstrate 
that the transgenic product NFM-CA50 is expressed  pri- 
marily in neurons, is transported into axons, and is colocal- 
ized (presumably coassembled) with endogenous neurofil- 
ament subunits both in cell bodies and in axons. 
Expression of NFM-CA50 Reduces Axonal 
Accumulation  of Wild-type NF-H and Inhibits 
Radial Growth 
For both transgenic lines, parallel blots (Fig. 3, A-C) were 
Figure 3.  Expression of NFM-CA50 decreases axonal NF-H ac- 
cumulation in sciatic nerves and ventral roots.  (A) (left) 10 ~g of 
total protein extracts of sciatic nerve from 1.5-too-old mice carry- 
ing both line 2 and line 42 transgenes (42 x  2), the line 42 trans- 
gene only (42), the line 2 transgene only (2),  or age-matched 
wild-type (wt) mice were immunoblotted  with either (left) a mAb 
against NF-L,  the  myc-9E10 mAb, the  RMO255  mAb, fol- 
lowed by rabbit anti-mouse secondary antibody and 125I-labeled 
protein A,  or  a  polyclonal, phosphorylation-independent anti- 
body against NF-H followed by 125I-labeled  protein A. A series of 
twofold dilutions of a bacterial extract containing  a fusion protein 
carrying the epitope tag or purified wild-type mouse neurofila- 
ments were immunoblotted in parallel for quantification. (Right) 
Similar blots probed with the phosphorylation-dependent neu- 
rofilament antibody SMI-31. (B) Protein blots similar to A except 
from extracts  of ventral roots. Samples shown represent indepen- 
dent analyses from two wild-type and two transgenic animals. (C) 
Quantitative analysis (via phosphorimaging) of blots similar to 
those in (A and B) are displayed for wild-type (wt) and transgenic 
(tg) NFM-CA50(42) mice at 1.5 or 9 months-of-age. The neurofil- 
ament subunit composition in moles are normalized to total pro- 
tein. Each point represents the average of immunoblot quantifi- 
cations  of  nerve  extracts  from  three  different  mice  for  each 
group. Standard errors for these measurements are given in Ta- 
ble I. Open domains, NF-L; striped domains, NF-M; stippled do- 
mains,  NFM-CA50,  and solid  domains,  NF-H.  (D)  Coomassie 
blue staining of sciatic nerve extracts  from lines 42, 2, and wild- 
type mice.  NFH: endogenous NF-H; NF-M: endogenous NFM; 
C50: transgenic NFM-CA50; and NFL: endogenous NF-L. Closed 
circles  indicate the  bands corresponding to  the  neurofilament 
subunits. Open circle  denotes a  nonneurofilament protein mi- 
grating close to NF-H and whose abundance is highly variable in 
animals of the same genotype. Molecular mass standards are de- 
noted at the left (kD). 
performed  to  quantify the  accumulation of endogenous 
NF-L, NF-M, and NF-H, as well as transgene-encoded  NF-M 
in sciatic nerve and in L5 ventral root. Measurement of abun- 
dance of each neurofilament subunit in each animal was 
performed in duplicate and quantified by phosphorimag- 
ing using standards derived from serial dilutions of known 
amounts of purified wild-type neurofilament subunits or a 
bacterially produced fusion protein carrying the  epitope 
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hand portion of C) that in line 42 at 1.5 mo of age, neu- 
ronal expression of transgenic NF-M amounted to ~130% 
the  level of NF-M in nontransgenic  littermates. Partially 
compensating for the transgene accumulation, endogenous 
NF-M levels in the transgenic animals declined  to ~60% 
of the normal level, resulting in a total NF-M subunit level 
of ~190%  of the wild-type level in the transgenic ventral 
root.  Using  a  phosphorylation-independent  antibody  to 
the  carboxy-terminal 15  amino acids of NF-H (which  lie 
207 amino acids from the lysine-serine-proline phosphor- 
ylation domain), axonal NF-H level was found to be mark- 
edly reduced  (Fig. 3, B  and  C), falling to only ~40%  of 
that  in  the  nontransgenic  control.  NF-L levels were  not 
changed  significantly  in  the  transgenic  ventral  root  (to 
~90% of wild-type). 
Similar examination of sciatic nerves from two indepen- 
dent measurements from six transgenic animals (line 42) 
up to nine months of age (Fig. 3, A  and C) revealed that 
while transgenic NF-M levels continued to increase during 
aging (from 180%  at 1.5 mo to ,-~230%  of NF-M in wild- 
type mice), axonal levels of endogenous NF-M and NF-H 
subunits remained low (,-o50%  of that in control animals). 
NF-L levels were elevated slightly (~25%  at 1.5 months). 
Coomassie staining of sciatic nerve extracts (Fig. 3 D) con- 
firmed that accumulation of transgenic NF-M was accom- 
panied by approximate twofold decreases in both endoge- 
nous NF-H and NF-M, while NF-L levels were unaltered. 
Immunoblotting  with  an  NF-H  antibody  (SMI-31)  that 
recognizes only phosphorylated NF-H (Fig. 3 A, right) re- 
vealed the same twofold diminution as did the phosphor- 
ylation-independent  antibodies  (Fig.  3 A, top  row,  /eft); 
hence, the average degree of phosphorylation of each NF-H 
polypeptide was equivalent in wild-type and NF-M trans- 
genic nerves. 
Inspection of motor axons in ventral roots and sensory 
axons in dorsal roots of 1.5-mo-old transgenic animals re- 
vealed an obvious difference between wild-type and trans- 
genic NFM-CA50 lines 2 or 42. The diameters of the myeli- 
nated  axons  of  the  transgenic  animals  were  markedly 
smaller (shown in Fig. 4 for line 42). Detailed morphomet- 
ric analysis to measure the area of every myelinated axon 
within a ventral root confirmed this initial impression (Fig. 
5, A  and B): although the smallest caliber axons were un- 
changed in abundance or diameter, the radial growth that 
accompanies  myelination  during  the  first  two  to  three 
postnatal weeks was reduced significantly in the transgenic 
axons. At 1.5  mo of age, despite an increased content of 
NF-M (representing the combination of transgenic and en- 
dogenous NF-M; see above, Fig. 3 C) and a normal level of 
NF-L, the average calibers of the largest myelinated axons 
in the L5 ventral root were only ~3.5 txm in the transgenic 
animals compared with ~5 txm in littermate controls (Fig. 
5 A). This corresponds to an axonal cross-sectional area in 
the  transgenic mice of only ~50%  that of the wild-type. 
The substantially reduced radial growth was paralleled by 
the >50% diminution of axonal NF-H (Fig. 3, B and C), a 
finding strongly suggesting that the NF-H subunit is a ma- 
jor determinant for the normal radial growth phase of an 
axon. 
Measurement  of  the  total  number  of  axons  between 
control and transgenic nerve root revealed them to be es- 
Figure 4.  Smaller axonal calibers in motor and sensory axons in 
mice expressing NFM-CA50. Light micrographs display cross sec- 
tions from dorsal or ventral roots from 1.5-mo-old mice from line 
NFM-CzX50(42) or wild-type mice. Bar, 5 Ixm. 
sentially  identical  (i.e.,  930  ---  36  and  945  +--  36,  respec- 
tively, for the L5 root; see Table I). Hence, the transgene- 
dependent shift in axon caliber cannot be due to selective 
loss of large myelinated fibers. Nor is reduction in caliber 
likely to be due to the replacement of large fibers with re- 
generating sprouts, since myelin sheath thicknesses are not 
altered, and inspection of roots and nerves failed to reveal 
the  presence of degenerating  axons  (see  below).  As  the 
animals age, there was a  continuing 1.7-2-fold transgene- 
dependent  inhibition  of growth in  axonal cross-sectional 
area, with the average diameters of the largest myelinated 
axons at 9 mo remaining smaller in transgenic animals (~8 
Ixm in the transgenic mice compared with ~10 txm in con- 
trols; Fig. 5 B). Retardation of radial growth continued to 
correlate with reduction in the level of axonal NF-H (Fig. 
3  C), while the overall molar level of neurofilament sub- 
units was similar in NF-M transgenic and control mice. 
Nearest Neighbor Spacing between 
Neurofilaments Is Unaffected by Increase in Axonal 
NF-M and Concomitant Reduction in NF-H 
To examine the mechanism through which increase in ax- 
onal NF-M and reduction in NF-H inhibit neurofilament- 
dependent radial growth, the distribution of filaments was 
examined in cross sections of ventral roots from wild-type 
and  NF-M  transgenic  animals.  This  revealed  a  similar 
packing  of  filaments  between  wild-type  (Fig.  6  A)  and 
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Figure 5.  Smaller axonal calibers in motor and sensory axons in 
mice expressing NFM-CA50. Quantitative analysis of axon diam- 
eters in L5 ventral roots from control and NFM-C2~50(42) trans- 
genic animals  at 1.5 (A) and at 9 months of age (B). Each fre- 
quency  plot of axon diameter represents the average values  of 
three animals, except for the 9-mo-old control group (two animals). 
transgenic  (Fig.  6  B)  axons.  As one plausible hypothesis 
was that the heavily phosphorylated tail of NF-H may de- 
termine interfilament  distance  and  specify radial growth 
by forming direct crossbridges between adjacent filaments 
(e.g., as initially proposed by Hirokawa al., 1984),  we ex- 
amined how diminution of NF-H affects nearest neighbor 
filament spacing. Positions of all neurofilaments within 10 
ventral root axons were established and the distribution of 
nearest neighbors calculated (Fig. 6 C). Despite an ~50% 
reduction in NF-H (Fig. 3) and a corresponding inhibition 
of radial growth  (Fig.  5),  the  distributions  of nearest  in- 
terfilament spacings were indistinguishable between NF-M 
transgenic and littermate control mice (Fig. 6 C). 
Figure  6.  Neurofilament  organization  in  axons  from  wild-type 
mice or mice expressing elevated levels of NFM-C~50. Axoplasm 
from cross section of an L5 ventral root axon from a  1.5-mo-old 
(a) wild-type or (b) NFM-CA50 mouse. Bar, 0.5 txm. (c) The dis- 
tribution  of nearest neighbor distances between  neurofilaments 
in  ventral  root  axons  from  (top)  wild-type  or  (bottom)  NFM- 
CA50(42) mice. 
Expression of NFM-C  A50 Generates Filament 
Accumulation in Cell Bodies and Proximal Axons 
No overt phenotype was observed in NF-M mice at any 
point between  1.5  and 24 mo of age.  However, to assess 
Table L Neurofilament Content, Axonal Caliber and Pathology in NF-M Transgenic Mice 
mouse line 
NFM-CA50 (42)  Wild type 
1.5 mo  9  mo  1.5 mo  9  mo 
Axonal swellings 
Swollen motor neuron perikarya 
Number of axons in L5 ventral root* 
Number of axons in L4, L5, and L6 ventral roots* 
Average axonal area (ixm  2) 
Average caliber of large diameter axons in ventral root (p,m) 
Total NF content in ventral root (pmol/txg) 
NF-H content in ventral root (pmol/p,g) 
NF-M content in ventral root (pmol/ixg) 
NF-L content in ventral root (pmol/p,g) 
"~5/section  ~5/section  None  None 
10/section  ~  10/section  None  None 
945 (_+41)  1035 (+48)  930 (__-36)  993 (_+ 16) 
ND  2396 (--+61)  ND  2366 (_+ 18) 
*2278 (-4-72) 
9.42  50.2  19.6  78.5 
3.50  08  5  10 
1.4 (-+0.35)  ND  1.30 (__-0.29)  ND 
0.08 (_+0.02)  ND  0.20 (__-0.03)  ND 
0.76 (_+0.18)  ND  0.40 (_+0.08)  ND 
0.60 (_+0.15)  ND  0.70 (_+0.18)  ND 
*Average of root(s) from at least two animals (-SD). 
*NFM-CA50,  line 42 × 2. 
The Journal of Cell Biology,  Volume 130, 1995  1418 Figure 7.  Expression of NFM-CA50 generates massive filament accumulation within swollen cell bodies and proximal axons of spinal 
motor neurons. Toluidine blue-stained (1 txm) sections from the anterior horn of a spinal cord from control (A and C) and a 1-mo-old 
MSV-NFM-CA50(2) transgenic animal (B and D). Bar in A  and B, 80 I~m; bar in C and D, 20 Ixm. (E-G) Electron micrographs of a mo- 
tor neuron from a 1.5-mo-old MSV-NFM-CA50(42) transgenic animal. Higher magnification of the boxed areas reveals (F) massive ac- 
cumulation of filaments in the cytoplasm and (G) aggregation of RER. Bar in E, 10 Izm; bar in F, 2 Izm; bar in G, 1 ~zm. (H and i) Elec- 
tron micrographs of a proximal axonal swelling from the same spinal cord as in (E). Bar in H, 5 i~m; bar in L 1 ~m. 
Wong et al. Increasing NF-M lnhibits Radial Growth  1419 Figure 8.  Neurofilamentous accumulation  in large  sensory neu- 
rons of dorsal root ganglia. 1-1xm sections of dorsal root ganglia 
from control  (A)  and  1.5-mo-old  MSV-NFM-CA50(42)  trans- 
genic (B) animal stained with toluidine blue. Bar, 30 Ixm. 
whether there were morphological consequences of NFM- 
CA50  expression in  neurons,  eight  transgenic mice from 
both lines 42 and 2, as well as age-matched controls, were 
perfused at various ages (postnatal d 26 to 5 mo) and their 
tissues were processed for both light and electron micros- 
copy (summarized in Table I). Striking morphological al- 
terations in NFM-CA50(2) mice were observed as early as 
day 26 in  the  anterior horn  motor neurons.  Most of the 
motor  neurons  displayed  distended,  swollen  perikarya 
(Fig. 7, B and D) compared with nontransgenic littermates 
(Fig. 7, A  and C). At the electron microscopic level, these 
swellings  consisted  of massive bundles  of tightly packed 
filaments (Fig. 7, E  and F).  Indirect double immunofluo- 
rescence  demonstrated  that  these  filament  bundles  con- 
tain  both  transgene  and  endogenous  NF  subunits  (see 
above; Fig. 2, G and H). Swirls of filaments occupy most of 
the cytoplasmic volume, which in turn results in the aggre- 
gation of RER around the  nucleus  (Fig.  7 E),  as well as 
patches scattered throughout the cytoplasm (see close-up 
in  Fig.  7  G).  In contrast,  the  RER  is  distributed  evenly 
throughout  the  cytoplasm  in  wild-type  perikarya  (not 
shown).  Another prominent characteristic of motor neu- 
rons in NFM-CA50 mice was numerous proximal axonal 
swellings (Fig. 7 H). When observed at higher magnifica- 
tion, accumulations of massive bundles of filaments were 
obvious in these swollen axonal segments (Fig. 7/). 
To examine whether expression of NFM-CA50 also af- 
fected neurons besides spinal motor neurons, the nervous 
system of a mouse from line 2 was surveyed (Fig. 8). Neu- 
rofilament  masses  were  readily  apparent  in  other  large 
neurons, including prominent accumulations in the largest 
sensory neurons of the dorsal root ganglia. Most of these 
were distended with arrays of neurofilaments (lightly stained 
areas in Fig. 8 B), although examination of the entirety of 
the dorsal root did not reveal any axonal degeneration. Neu- 
rofilamentous accumulation was also observed in other types 
of neurons, including pyramidal neurons from the hippo- 
campus, the  large  neurons  in  the  trigeminal  sensory nu- 
cleus, and the motor neurons in the facial nucleus of the 
brainstem (data not shown). A  common thread among all 
these  different  types  of neurons  that  show  morphologic 
abnormalities as a consequence of NFM-CA50 accumula- 
tion is that they represent large neurons, each with a high 
normal neurofilament burden. 
Neither the perikaryal or axonal accumulations resulted 
in an elevated frequency of axonal degeneration, as no de- 
generating axons were observed in examination of the en- 
tirety of L4 through L6 ventral roots from two transgenic 
animals either  at  1.5  or 9  months of age.  Count  of axon 
number in L5 ventral roots further revealed no significant 
difference  between  transgenic  and  wild-type  animals  at 
any age (Table I). 
Discussion 
To earlier linkage of neurofilament accumulation as an in- 
trinsic  determinant  of axonal caliber,  our present results 
provide  proof  that  neurofilament  subunit  composition 
plays an important role in establishment and maintenance 
of axonal caliber: at constant NF-L levels and slightly ele- 
vated total neurofilament content, transgene-encoded NF-M 
raised overall NF-M levels, and yet inhibited radial growth 
concomitant  with  reduction  in  endogenous  NF-H.  The 
simplest interpretation is that axonal NF-H is the primary 
determinant  of radial  growth,  while  the  more  abundant 
NF-L subunit provides the basic framework for core fila- 
ment assembly. Such  a  conclusion is also consonant with 
earlier efforts demonstrating a correlation between radial 
growth and phosphorylation of the tail domains of NF-M 
and NF-H both in the initial axonal segment (Hsieh et al., 
1994; Nixon et al., 1994), in nodes (Hsieh et al., 1994), and 
in response to demyelination (deWaegh et al., 1992).  It is 
also consistent with the finding that proximal axons are in- 
creased in size after expression of wild-type human NF-H 
in transgenic mice (Cote et al., 1993) and the severe inhibi- 
tion of radial growth after blockage of NF-H (along with 
NF-L and NF-M) transport into axons after expression of 
a truncated NF-H fused to the entirety of [3-galactosidase 
(Eyer and Peterson, 1994). 
The loss of endogenous NF-H as a  consequence  of in- 
creasing NF-M expression, while NF-L levels remain un- 
changed,  demonstrates  an  in  vivo  competition  between 
accumulation of NF-M and NF-H. The nature of the com- 
petition could arise from competition either as substrates 
for the slow axonal transport machinery or for coassembly 
with  NF-L,  which  at  least  in  the  transgenic  neurons,  is 
present in limiting amounts. The latter view is fully consis- 
tent with the finding that assembly of neurofilament net- 
works after expression in nonneuronal cells requires NF-L 
and  substoichiometric amounts  of either NF-M  or  NF-H 
(Ching and Liem, 1993; Lee et al., 1993). 
Although  NF-H  (and its phosphorylation)  must be  an 
important element for specifying caliber, we  would  note 
that the evidence does not yet formally exclude a contribu- 
tion from NF-M, since the partial replacement of endoge- 
nous  NF-M  with  the  slightly  truncated,  epitope-tagged 
NF-M subunit could reduce (or eliminate) such an activity. 
However,  similar  tagging  (with  even  significantly  larger 
carboxy-terminal truncations) has not been found to affect 
coassembly  properties  with  NF-L,  either  in  transfected 
mammalian cells  (Lee  et  al.,  1993)  or  in  insect  cells in- 
fected with baculoviruses encoding both NF-L and NF-M 
(Nakagawa et al., 1995).  Moreover, in the latter example, 
filament-filament spacing properties are identical for wild- 
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truncated by 95 amino acids (Nakagawa et al., 1995). At a 
minimum, even if the transgene-encoded NF-M does func- 
tion  slightly  aberrantly,  a  strong  conclusion  remaining 
would be that both NF-H and NF-M are necessary for nor- 
mal radial growth. Since in the absence of neurofilament 
investment large myelinated axons achieve only ~1/6  of 
their normal cross-sectional areas either in quails (Sakagu- 
chiet al., 1993) or in mice (Eyer and Peterson, 1994), this 
would be particularly appealing given that even with de- 
pressed NF-H levels, significant growth does still occur in 
the NF-M transgenic axons both during myelination and 
increasing in later life (compare Fig. 5, A and B). 
As to the mechanism through which neurofilaments me- 
diate growth in caliber, a plausible view has been that the 
highly phosphorylated  tail  domain  of NF-H orders  axo- 
plasmic structure  through  interaction  (crossbridging) be- 
tween  adjacent  neurofilaments.  This  idea  arose  initially 
from demonstration  using  immunocytochemistry that  in 
vivo  crossbridges  between  filaments  were  comprised  of 
NF-H tails  (Hirokawa  et  al.,  1984).  The  current  finding 
that nearest neighbor distributions between wild-type and 
NF-M-transgenic axons are indistinguishable strongly sug- 
gests that NF-M- (but not NF-H-) dependent interactions 
may serve to specify nearest neighbor spacing, while the 
phosphorylated NF-H tail may establish caliber through a 
three-dimensional filament scaffold arising from tail-medi- 
ated,  longer  range  crossbridging  between  filaments that 
are not nearest neighbors and/or through interactions with 
other  axonal components, such  as  microtubules,  cortical 
actin arrays, and potentially many other components. Fur- 
ther, it seems likely that phosphorylation of the NF-M tail 
may determine (or at least influence) the minimal interfil- 
ament  distance.  An  ~50~nm  spacing  is  found  in  myeli- 
nated axons where NF-M is fully phosphorylated, whereas 
only an ~30-nm filament-filament spacing is seen where 
NF-M is unphosphorylated (i.e., the initial axonal segment 
[Hsieh et al., 1994] and in insect cells expressing NF-L and 
NF-M [Nakagawa et al., 1995]). 
Abnormal neurofilamentous accumulations in the peri- 
karya and proximal axons of motor neurons, an early hall- 
mark  of  human  motor  neuron  diseases  such  as  amyo- 
trophic  lateral  sclerosis  (ALS)  (Carpenter,  1968;  Inoue 
and Hirano, 1979;  Hirano et al.,  1984  a,b; Banker,  1986; 
Saskai et al., 1988;  for review see Hirano, 1991), initially 
suggested that neurofilaments may play an important role 
in the pathogenesis of this disorder.  Clinically character- 
ized by degeneration and loss of motor neurons followed 
by progressive, denervation-induced muscle atrophy (Tower, 
1939; Mulder, 1984,  1986), the mechanism(s) of pathogen- 
esis is unknown, although mutations in superoxide dismu- 
tase  are  known  to  cause  a  small  percentage  of  cases 
(Rosen et al.,  1993).  Direct evidence that aberrant accu- 
mulation of neurofilaments can play an integral part in mo- 
tor neuron  disease  has  emerged from the  efforts of two 
groups who independently have shown that two- to four- 
fold  overexpression  in  transgenic  mice  of either  mouse 
NF-L (Xu et al., 1993) or human NF-H (Cote et al., 1993; 
Collard et al., 1995) does result in aberrant neurofilamen- 
tous accumulations and some of the pathological features 
that resemble those found in ALS. Moreover, expression 
of a point mutant in NF-L at the level expected from a sin- 
gle gene in a diploid cell produces not only this pathology, 
but also selective motor neuron death (Lee et al., 1994). 
To this, the present results prove that an approximately 
twofold elevation of NF-M results in altered ratios of the 
three  neurofilament  subunits  and  abnormal  flamentous 
aggregates in neuronal cell bodies and axons. Hence, when 
combined with the earlier work (Cote et al.,  1993;  Xu et 
al., 1993;  Collard et al., 1995), significant increases in any 
neurofilament subunit can produce pathology characteris- 
tic of the early phases of motor neuron disease (for review 
see Hirano, 1991). In each instance, the most severely af- 
fected  neurons  are  the  large,  neurofilament-rich  motor 
neurons,  although  morphological  abnormalities  are  also 
found in peripheral sensory neurons and a few other large 
neurons  of the central nervous system that are naturally 
abundant in neurofilaments. This mimics the pathology re- 
ported by a series of workers for the late stages of ALS, 
where besides prominent defects in motor neurons, there 
is also evidence demonstrating an involvement of sensory 
neurons  (Kawamura et al.,  1981;  Averback and  Croker, 
1982; Radtke et al., 1986). 
With  regard  to how neurofilaments  can provoke neu- 
ronal failure, only very high doses of NF-L result in dis- 
ease (Xu et al., 1993), whereas a severalfold smaller molar 
increase of human NF-H subunits is equally pathogenic in 
mice  (Cote  et  al.,  1993).  Despite  neurofilament-induced 
neuronal  failure,  in  neither  instance  is  there  significant 
neuronal death (for NF-L, see Xu et al., 1993;  for NF-H, 
see  Fig.  1  b  of  Collard  et  al.,  1995).  Increasing  NF-M 
levels, at least to the levels achieved here, does not lead to 
an overt phenotype or axonal degeneration, despite peri- 
karyal filamentous swellings  and  a  slight increase  in the 
overall axonal burden of filament subunits. A unifying view 
for how filaments provoke disease would be that it is pri- 
marily  axonal  accumulations  that  ar~  pathogenic,  most 
probably by an increasing burden  of filaments adversely 
affecting axonal transport.  In this view, increasing NF-L 
may  lead  to  many more  axonal  filaments,  which  when 
present at sufficient levels retard (potentially block) slow 
axonal transport. For NF-H, whose abundance is known to 
correlate inversely with the speed of slow transport (Wil- 
lard and Simon, 1983), increasing its levels in proximal ax- 
ons  and perikarya strongly retards  transport  (Collard  et 
al., 1995).  On the other hand, increasing NF-M would have 
a much smaller effect for two reasons: (1) a limiting level 
of NF-L prevents additional axonal filament assembly, and 
(2) competition between NF-H and an increased level of 
NF-M yields decreased axonal NF-H abundance. 
In any event, along with earlier reports on NF-L (Xu et 
al., 1993) and NF-H (Cote et al., 1993), our present results 
establish that primary changes in abundance of any of the 
three neurofilament subunits are sufficient to recapitulate 
some of the early pathologic features observed in motor 
neuron diseases such as ALS. These findings combine to 
suggest that even in disorders (like ALS arising from mu- 
tation  in  superoxide  dismutase)  where  accumulation  of 
neurofilaments are secondary to other types of neuronal 
insult, axonal neurofilament accumulation may play an es- 
sential pathogenic role in neuronal failure. 
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